Point mutations and single base mutations are the dominant
mutations
found in the KRAS gene. Systematic knockout of the KRAS gene with
these point mutations is still challenging. In this study, we developed
novel photo-cross-linking oligonucleotides (<sup><b>p</b></sup><b>U</b><sub><b>1</b></sub><b>–ODN</b> and <sup><b>p</b></sup><b>U</b><sub><b>2</b></sub><b>–ODN</b>) that had a diazirine group at the 5-position
of the uridine derivatives. Photo-cross-linking studies of the oligonucleotides
with wild-type and mutated RNAs revealed that <sup><b>p</b></sup><b>U</b><sub><b>2</b></sub><b>–ODN</b> efficiently
and selectively reacts with the mutated RNAs that contain a cytidine,
guanosine, or uridine residue at the frontal position of the <sup><b>p</b></sup><b>U</b><sub><b>2</b></sub> nucleoside.
These results suggest that <sup><b>p</b></sup><b>U</b><sub><b>2</b></sub><b>–ODN</b> is a promising
candidate for use as a photo-cross-linking ODN to selectively inhibit
the activity of mRNAs with a point mutation.